Experience with 4′-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosis
- 28 February 1974
- journal article
- Published by Elsevier in European Journal of Cancer (1965)
- Vol. 10 (2), 93-98
- https://doi.org/10.1016/0014-2964(74)90058-9
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Clinical Screening of Epipodophyllotoxin VM26 in Malignant Lymphomas and Solid TumoursBMJ, 1972
- 4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of actionEuropean Journal of Cancer (1965), 1970
- Therapie karzinomatöser Endstadien mit SP-G und SP-I1Deutsche Medizinische Wochenschrift (1946), 1964